Coronary/Structural Heart Boston Scientific says Lotus out until Next Year Shared by Ken Dropiewski on February 2, 2018 More in Coronary/Structural Heart: Eight-Year Data Confirm Long-Term Durability of Edwards’ RESILIA Tissue April 18, 2025 FDA Clearance and First in Human Use for SoloPace™ Temporary Pacing System for TAVR April 17, 2025 Daxor Corporation to Showcase Innovative Blood Volume Analysis at MedAxiom Cardiovascular Transforum Spring 2025 April 17, 2025 Share this story Facebook Twitter LinkedIn Lotus Valve to Stay Off the Shelves Through 2018 Patrice Wendling – February 01, 2018, Medscape MARLBOROUGH, MA — The beleaguered Lotus heart valve system is not expected to launch in the US market until 2019, according to Boston Scientific officials. All Lotus valves were voluntarily recalled worldwide in February 2017 because of reports of early release of a pin connecting the transcatheter valve to the delivery system…. Read Full Article at Medscape here